Has an FDA-cleared technology considered to be the gold standard in non-invasive central blood pressure ✅
Exposure to US healthcare markets ✅
Deep into the US telehealth sector worked with the biggest players such as Anthem (NSYE: ANTM) ✅
Showing leadership in the exciting and massive world of future health care ✅
Making strides in the US and now in China ✅
Right sector and management ✅
Cutting edge technology products in the R&D development pipeline ✅
Share price doing well with increased volume ✅
Well funded now after the recent cap raise ( No discount and was investor lead) ✅
‘When combined with a current cash balance of ~$2.4m, the company is well funded to achieve its current milestones related to wearable technologies and new medical device developments’
Good luck everyone. DYOR!
Add to My Watchlist
What is My Watchlist?
